Fig. 1From: Points to consider: efficacy and safety evaluations in the clinical development of ultra-orphan drugsComposition of data package. Forty-three ultra-orphan drugs and 88 orphan drugs other than ultra-orphan drugs approved in Japan from January 2001 to December 2014. The numbers in the figure are the numbers of drugsBack to article page